Jacobi Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $333K | Sell |
6,733
-90
| -1% | -$4.57K | 0.02% | 541 |
|
|
2026
Q1 | $364K | Sell |
6,823
-439
| -6% | -$25.8K | 0.02% | 496 |
|
|
2025
Q4 | $451K | Buy |
7,262
+6
| +0.1% | +$370 | 0.03% | 433 |
|
|
2025
Q3 | $436K | Sell |
7,256
-76
| -1% | -$4.65K | 0.03% | 424 |
|
|
2025
Q2 | $459K | Sell |
7,332
-11
| -0.1% | -$661 | 0.03% | 404 |
|
|
2025
Q1 | $442K | Sell |
7,343
-553
| -7% | -$34.3K | 0.03% | 390 |
|
|
2024
Q4 | $461K | Sell |
7,896
-967
| -11% | -$57.5K | 0.03% | 365 |
|
|
2024
Q3 | $525K | Sell |
8,863
-163
| -2% | -$9.31K | 0.04% | 336 |
|
|
2024
Q2 | $506K | Sell |
9,026
-504
| -5% | -$28.2K | 0.04% | 312 |
|
|
2024
Q1 | $558K | Buy |
9,530
+154
| +2% | +$8.7K | 0.05% | 290 |
|
|
2023
Q4 | $506K | Buy |
9,376
+251
| +3% | +$12.3K | 0.05% | 287 |
|
|
2023
Q3 | $443K | Sell |
9,125
-29
| -0.3% | -$1.54K | 0.05% | 291 |
|
|
2023
Q2 | $517K | Buy |
9,154
+633
| +7% | +$34.9K | 0.06% | 269 |
|
|
2023
Q1 | $460K | Sell |
8,521
-188
| -2% | -$10K | 0.05% | 284 |
|
|
2022
Q4 | $458K | Buy |
8,709
+886
| +11% | +$45K | 0.06% | 281 |
|
|
2022
Q3 | $369K | Sell |
7,823
-60
| -0.8% | -$3.11K | 0.05% | 294 |
|
|
2022
Q2 | $398K | Buy |
7,883
+387
| +5% | +$21.1K | 0.05% | 289 |
|
|
2022
Q1 | $457K | Sell |
7,496
-99
| -1% | -$5.9K | 0.05% | 280 |
|
|
2021
Q4 | $500K | Sell |
7,595
-22
| -0.3% | -$1.41K | 0.06% | 276 |
|
|
2021
Q3 | $478K | Buy |
7,617
+1,161
| +18% | +$74.1K | 0.06% | 258 |
|
|
2021
Q2 | $388K | Buy |
6,456
+42
| +0.7% | +$2.43K | 0.05% | 280 |
|
|
2021
Q1 | $353K | Buy |
6,414
+294
| +5% | +$16.3K | 0.05% | 270 |
|
|
2020
Q4 | $334K | Buy |
6,120
+6
| +0.1% | +$314 | 0.05% | 258 |
|
|
2020
Q3 | $305K | Buy |
6,114
+216
| +4% | +$10.5K | 0.05% | 248 |
|
|
2020
Q2 | $260K | Buy |
5,898
+90
| +2% | +$3.85K | 0.05% | 256 |
|
|
2020
Q1 | $218K | Buy |
5,808
+210
| +4% | +$8.84K | 0.05% | 246 |
|
|
2019
Q4 | $247K | Buy |
5,598
+12
| +0.2% | +$504 | 0.05% | 262 |
|
|
2019
Q3 | $230K | Sell |
5,586
-120
| -2% | -$4.91K | 0.05% | 262 |
|
|
2019
Q2 | $229K | Buy |
5,706
+6
| +0.1% | +$227 | 0.05% | 260 |
|
|
2019
Q1 | $220K | Sell |
5,700
-30
| -0.5% | -$1.09K | 0.06% | 217 |
|
|
2018
Q4 | $191K | Buy |
5,730
+702
| +14% | +$24.3K | 0.05% | 225 |
|
|
2018
Q3 | $191K | Sell |
5,028
-156
| -3% | -$5.54K | 0.05% | 227 |
|
|
2018
Q2 | $173K | Buy |
5,184
+666
| +15% | +$21.7K | 0.05% | 230 |
|
|
2018
Q1 | $136K | Buy |
4,518
+54
| +1% | +$1.66K | 0.04% | 247 |
|
|
2017
Q4 | $135K | Buy |
4,464
+342
| +8% | +$9.86K | 0.04% | 216 |
|
|
2017
Q3 | $116K | Buy |
4,122
+528
| +15% | +$14.6K | 0.04% | 220 |
|
|
2017
Q2 | $99K | Buy |
+3,594
| New | +$95.2K | 0.04% | 209 |
|
Other funds holding IHI
AAS
Jacobi Capital Management's IHI Position: Q2 2026 in Review
Jacobi Capital Management reduced its iShares US Medical Devices ETF (IHI) stake by 1.3% in Q2 2026, selling an estimated $4.57K and leaving 6,733 shares worth $333K. The position accounts for 0.02% of the portfolio, ranked #541.
Jacobi Capital Management first reported a position in IHI in Q2 2017 and has held it in 37 quarters since. The position peaked at $558K in Q1 2024. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Jacobi Capital Management held 6,733 shares of iShares US Medical Devices ETF worth $333K as of Q2 2026.
- Jacobi Capital Management sold 90 iShares US Medical Devices ETF shares in Q2 2026, an estimated $4.57K.
- iShares US Medical Devices ETF made up 0.02% of Jacobi Capital Management's portfolio in Q2 2026, its #541 holding.
- Jacobi Capital Management first reported a position in iShares US Medical Devices ETF in Q2 2017 and has held it in 37 quarters since.
- Jacobi Capital Management's iShares US Medical Devices ETF position peaked at $558K in Q1 2024.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.